Clinical Trial Update: Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral valganciclovir to placebo for prevention of cytomegalovirus infection after lung transplantation has completed and results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Valcyte (valganciclovir)

Snippet

Sponsor: Duke University | Conditions: Cytomegalovirus Infections | Phase 3 | Status: COMPLETED | Results posted: 2013-04-29